Back to today’s briefing

Story perspectives

Breakthrough: MICB Gene Targets Systemic Sclerosis Treatment

6/20/2025

40 4

Summary

Story summary

Researchers at Baylor College of Medicine have made a groundbreaking discovery in the fight against systemic sclerosis (SSc) by identifying the MICB gene as a potential therapeutic target. Utilizing exome sequencing and machine learning, this study underscores the importance of innovative strategies in unraveling the complexities of such challenging diseases, as detailed in the Annals of Rheumatic Diseases.

1 of 1

Story summary

Researchers at Baylor College of Medicine have made a groundbreaking discovery in the fight against systemic sclerosis (SSc) by identifying the MICB gene as a potential therapeutic target. Utilizing exome sequencing and machine learning, this study underscores the importance of innovative strategies in unraveling the complexities of such challenging diseases, as detailed in the Annals of Rheumatic Diseases.